Jornay Pm
Attention Deficit Hyperactivity Disorder
Treatment
1 FDA approval
20 Active Studies for Jornay Pm
Treatment for
Attention Deficit Hyperactivity Disorder
What is Jornay Pm
Dexmethylphenidate
The Generic name of this drug
Treatment Summary
Dexmethylphenidate is a stimulant drug used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adults. It was introduced in 2002 and works by increasing the activity of two neurotransmitters, norepinephrine and dopamine, in the brain. It is thought to be more effective than other forms of methylphenidate with fewer side effects.
Ritalin
is the brand name
Jornay Pm Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ritalin
Dexmethylphenidate
1955
400
Approved as Treatment by the FDA
Dexmethylphenidate, otherwise known as Ritalin, is approved by the FDA for 1 uses including Attention Deficit Hyperactivity Disorder .
Attention Deficit Hyperactivity Disorder
Helps manage Attention Deficit Hyperactivity Disorder (ADHD)
Effectiveness
How Jornay Pm Affects Patients
Dexmethylphenidate is a form of the drug methylphenidate. It is more powerful than the usual form, and works by blocking the reuptake of norepinephrine and dopamine in the brain.
How Jornay Pm works in the body
Methylphenidate works by blocking dopamine and norepinephrine transporters in certain areas of the brain, like the thalamus and striatum. This has been shown to affect blood flow and activity in parts of the brain, like the striatum, supplementary motor area, and posterior parietal cortex.
When to interrupt dosage
The proposed dosage of Jornay Pm is contingent upon the determined condition. The amount of dosage shifts, depending on the technique of administration (e.g. Tablet, film coated, extended release or Capsule, extended release) featured in the table beneath.
Condition
Dosage
Administration
Attention Deficit Hyperactivity Disorder
, 5.0 mg, 10.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 15.0 mg, 25.0 mg, 35.0 mg, 2.5 mg, 10.0 mg/mL, 5.0 mg/mL, 18.0 mg, 36.0 mg, 27.0 mg, 54.0 mg, 72.0 mg, 85.0 mg, 55.0 mg, 45.0 mg, 70.0 mg, 80.0 mg, 60.0 mg, 100.0 mg, 50.0 mg, 10.4 mg, 6.0 mg/mL, 5.2 mg, 9.0 mg/mL, 30.0 mg/mL, 7.5 mg/mL, 7.8 mg, 1.0 mg/mL, 2.0 mg/mL
, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Solution - Oral, Solution, Tablet, extended release - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release
Warnings
Jornay Pm has nine contraindications, and it is not to be taken along with any of the conditions outlined in the following table.
Jornay Pm Contraindications
Condition
Risk Level
Notes
Gilles de la Tourette syndrome
Do Not Combine
Tension-Type Headache
Do Not Combine
Agitation
Do Not Combine
Pulse Frequency
Do Not Combine
Tourette Syndrome
Do Not Combine
Tics
Do Not Combine
Generalized Anxiety Disorder
Do Not Combine
Open-angle glaucoma
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Dexmethylphenidate may interact with Pulse Frequency
There are 20 known major drug interactions with Jornay Pm.
Common Jornay Pm Drug Interactions
Drug Name
Risk Level
Description
Azelastine
Major
Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Desflurane
Major
Dexmethylphenidate may increase the hypertensive activities of Desflurane.
Diethyl ether
Major
Dexmethylphenidate may increase the hypertensive activities of Diethyl ether.
Enflurane
Major
Dexmethylphenidate may increase the hypertensive activities of Enflurane.
Ethanol
Major
Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Jornay Pm Toxicity & Overdose Risk
There is no difference in how men and women respond to dexmethylphenidate. Not much is known about how race, age, kidney and liver health, pregnancy, or breastfeeding affect the drug's effectiveness. Patients with kidney problems do not need a lower dose. Animal studies show that taking dexmethylphenidate during pregnancy or breastfeeding can delay fetal bone growth and reduce weight gain in male offspring. It is important to consider the benefits and risks of the drug before taking it. Dexmethylphenidate has not been linked to cancer, but mice exposed to extremely high doses developed liver tumors. There is also some weak evidence that it might be able to
Jornay Pm Novel Uses: Which Conditions Have a Clinical Trial Featuring Jornay Pm?
77 ongoing clinical trials are investigating the potential of Jornay Pm in providing relief for Attention Deficit Hyperactivity Disorder.
Condition
Clinical Trials
Trial Phases
Attention Deficit Hyperactivity Disorder
63 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2
Jornay Pm Reviews: What are patients saying about Jornay Pm?
5
Patient Review
8/24/2022
Jornay Pm for Attention Deficit Disorder with Hyperactivity
5
Patient Review
8/31/2022
Jornay Pm for Attention Deficit Disorder with Hyperactivity
5
Patient Review
9/14/2022
Jornay Pm for Attention Deficit Disorder with Hyperactivity
5
Patient Review
3/25/2022
Jornay Pm for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
11/13/2021
Jornay Pm for Attention Deficit Disorder with Hyperactivity
4.7
Patient Review
10/19/2022
Jornay Pm for Attention Deficit Disorder with Hyperactivity
2.7
Patient Review
3/2/2020
Jornay Pm for Attention Deficit Disorder with Hyperactivity
Patient Q&A Section about jornay pm
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does Jornay PM cause anxiety?
"The side effects of the medication may include mood changes, anxiety, feeling nervous or irritable, trouble sleeping; fast heart rate, pounding heartbeats or fluttering in your chest; loss of appetite, weight loss; dry mouth, nausea, vomiting, stomach pain, indigestion."
Answered by AI
How many hours does Jornay pm last?
"Jornay PM should be taken in the evening and it uses delayed-release and extended-release technology to keep it from working for about 12 hours after it is taken. It is proven to control ADHD symptoms from the time of waking up and it lasts throughout the day."
Answered by AI
Is Jornay pm the same as Ritalin?
"Jornay PM has the same active ingredient as Ritalin and Daytrana. The FDA considers Jornay PM to be a federally controlled substance because it can be abused or lead to dependence."
Answered by AI
What does Jornay PM do?
"JORNAY PM is a prescription medicine used to treat ADHD that works by stimulating the central nervous system. It is approved for use in people aged 6 and above."
Answered by AI